Online citations, reference lists, and bibliographies.

Licochalcone A Attenuates Acne Symptoms Mediated By Suppression Of NLRP3 Inflammasome

G. Yang, H. Lee, S. Yeon, H. Kang, Yong-Yeon Cho, H. Lee, C. Zouboulis, sin-Hee Han, Jeong-hoon Lee, J. Lee
Published 2018 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Activation of the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome by Propionibacterium acnes (P. acnes) is critical for inducing inflammation and aggravating the development of acne lesions. We searched for available small-molecule inhibitors of the NLRP3 inflammasome that could be topically administered for the treatment of acne. We found that licochalcone A, a chalconoid isolated from the root of Glycyrrhiza inflate, was an effective inhibitor for P. acnes-induced NLRP3 inflammasome activation. Licochalcone A blocked P. acnes-induced production of caspase-1(p10) and IL-1β in primary mouse macrophages and human SZ95 sebocytes, indicating the suppression of NLRP3 inflammasome. Licochalcone A suppressed P. acnes-induced ASC speck formation and mitochondrial reactive oxygen species. Topical application of licochalcone A to mouse ear skin attenuated P. acnes-induced skin inflammation as shown by histological assessment, ear thickness measurement, and inflammatory gene expression. Licochalcone A reduced caspase-1 activity and IL-1β production in mouse ear injected with P. acnes. This study demonstrated that licochalcone A is effective in the control of P. acnes-induced skin inflammation as an efficient inhibitor for NLRP3 inflammasome. Our study provides a new paradigm for the development of anti-acne therapy via targeting NLRP3 inflammasome.
This paper references
Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation
Jun Hu (2015)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou (2011)
Propionibacterium acnes induces IL-1β secretion via the NLRP3 inflammasome in human monocytes
M. Qin (2014)
New insights into acne pathogenesis: propionibacterium acnes activates the inflammasome.
E. Contassot (2014)
IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo.
Magdalena Kistowska (2014)
Propionibacterium acnes activates caspase‐1 in human neutrophils
Berolla Sahdo (2013)
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95).
C. Zouboulis (1999)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou (2011)
Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid
W. Worret (2006)
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout
H. Lee (2016)
Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation
G. Yang (2018)
Robert Gentleman, Vincent Carey, Wolfgang Huber, Rafael Irizarry, Sandrine Dudoit (2005): Bioinformatics and Computational Biology Solutions Using R and Bioconductor
J. Rahnenführer (2009)
IL‐1β drives inflammatory
L. Feldmeyer (2014)
Antibacterial Activity of Licochalcone A against Spore-Forming Bacteria
R. Tsukiyama (2002)
Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes
Tao Jia (2017)
Establishment and Characterization of an Immortalized Human Sebaceous Gland Cell Line (SZ95)1
C. Zouboulis (1999)
Fast gapped‐read alignment
B. Langmead (2012)
Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects
L. Kolbe (2006)
Fast gapped-read alignment with Bowtie 2
B. Langmead (2012)
A role for mitochondria in NLRP 3 inflammasome activation
R. Zhou
The fixed structure of Licochalcone A by alpha, beta-unsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-kappaB activation.
M. Funakoshi-Tago (2010)
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
G. Yang (2016)
Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome
G Yang (2018)
Inhibition by licochalcone A, a novel flavonoid isolated from liquorice root, of IL-1beta-induced PGE2 production in human skin fibroblasts.
Ikue Furuhashi (2005)
[Acne vulgaris].
M. Toscano (1992)
New developments in our understanding of acne pathogenesis and treatment
I. Kurokawa (2009)
Effect of Licochalcone A on Growth and Properties of Streptococcus suis
Huaijie Hao (2013)
Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.
Z. Li (2014)
New insights into acne pathogenesis
E. Contassot (2014)
R: A language and environment for statistical computing.
R. Team (2014)
Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study
M. Udompataikul (2011)
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages
S. Yeon (2017)
Randomized, double‐blind, split‐side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis
S. Wananukul (2012)
A double‐blind, randomized, vehicle‐controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne
I. Angelova-Fischer (2013)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar